BAKER BROS. ADVISORS LP 13D and 13G filings for Ascendis Pharma A/S:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:21 pm Sale | 2023-12-31 | 13G | Ascendis Pharma A/S ASND | BAKER BROS. ADVISORS LP | 0 0.000% | -4,954,855 (Position Closed) | Filing |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Ascendis Pharma A/S ASND | BAKER BROS. ADVISORS LP | 4,954,855 8.700% | 413,251 (+9.10%) | Filing |
| 2022-02-14 4:13 pm Purchase | 2021-12-31 | 13G | Ascendis Pharma A/S ASND | BAKER BROS. ADVISORS LP | 4,541,604 8.000% | 1,001,334 (+28.28%) | Filing |
| 2021-02-16 5:09 pm Purchase | 2020-12-31 | 13G | Ascendis Pharma A/S ASND | BAKER BROS. ADVISORS LP | 3,540,270 6.600% | 150,000 (+4.42%) | Filing |
| 2020-02-14 4:14 pm Purchase | 2019-12-31 | 13G | Ascendis Pharma A/S ASND | BAKER BROS. ADVISORS LP | 3,390,270 7.100% | 552,918 (+19.49%) | Filing |